Commentary

Find our newspaper columns, blogs, and other commentary pieces in this section. Our research focuses on Advanced Biology, High-Tech Geopolitics, Strategic Studies, Indo-Pacific Studies & Economic Policy

Public Health Guest User Public Health Guest User

Forewarned & Forearmed: Through G20 Presidency, India is at Right Position to Prevent Climate Disaster

By Harshit Kukreja & Mahek Nankani

The impacts of climate change are no longer just visible in the developing world. In 2022 itself, the effects were seen across the globe from heatwaves in India, to high temperatures in the UK to forest fires across several European nations. Most of these impacts are induced by anthropogenic activities. G20 which is a group of 19 countries and the European Union is responsible for most of the world’s greenhouse gas emissions. The countries make up about 2/3rd of the world population and 80% of Global GDP. The constituents of this group hold considerable sway over the world’s action towards climate change.

Read More
Public Health Guest User Public Health Guest User

Malnutrition: Is Public Nutrition the Best Approach?

By Harshit Kukreja

In India, with the initiation of schemes like POSHAN 2.0, nutrition is gradually gaining importance as an important aspect of health. With an increase in our understanding of health and nutrition, we are now able to test and prescribe individualised nutritional recommendations. Now, instead of population level recommended dietary allowance (RDA), it is possible to get personalised nutrition guidance based on comorbidities, genetic makeup and family history. As we just observed POSHAN maah (month) in September, let us talk about malnutrition.

Read More
Public Health, Advanced Biology Guest User Public Health, Advanced Biology Guest User

India@75: How India’s Health Report Since Independence Has Been Creditworthy

By Harshit Kukreja and Mahek Nankani

We are now in the third decade of the 21st century, seventy-five years after India gained Independence. In these years, the country has progressed in more sectors than one. The improvements across several health indicators are tremendous. These stories have been a result of conscious efforts towards achieving the goal of “Health for all”. As India heads towards becoming a superpower, it is important to look at the advancements we have made in the health sector.

Read More
Advanced Biology Guest User Advanced Biology Guest User

In Fight Against Monkeypox, Covid, Indoor Ventilation is a Key Tool in Reducing Risk of Infection

By Harshit Kukreja

We are facing an ever increasing caseload of Covid-19, which has reached 20,000 new cases every day. There is also an additional threat of monkeypox, which has been detected in India and has been declared a Global Health Emergency. Countries such as India and the UK have even advised airborne precautions pointing towards a risk of easy spread through respiratory droplets. Although, not as easily as Covid-19.

Masks, social distancing and vaccinations are existing tools, which are helping us fight Covid-19 and monkeypox. One important tool that we as a country have not used is indoor ventilation. Indoor ventilation means putting outdoor air inside and removing indoor air to reduce the risk of infection.

Read More
Advanced Biology Guest User Advanced Biology Guest User

Why Most Indians Not Using Public Health Facilities is a Matter of Concern

By Harshit Kukreja and Mahek Nankani

To facilitate and enhance the ongoing mass vaccination campaign for Covid-19, the government has made booster doses free for citizens above 18 years of age for 75 days, starting July 15. This announcement has come amidst the rise of Covid-19 cases across India. The decision is not only bold, but also smart. This is because a staggering 92% Indians, who are currently eligible for a third dose, have not yet taken their shots and are now late receivers. The move is targeting many objectives together: increasing affordability, improving accessibility to more groups and strengthening the trust of the people in government authorities. However, poor awareness and implementation can hinder the ultimate objective of the decision.

Read More
Advanced Biology Guest User Advanced Biology Guest User

What can we do to Ensure Monkeypox Doesn't become the Next Covid?

By Harshit Kukreja and Mahek Nankani

In addition to the recent surge in the number of Covid cases across several regions, India reported its first case of monkeypox virus last week in Kerala. The infected person is said to have reached the state capital recently from UAE and started feeling symptoms soon after landing. In the wake of the first confirmed case in the country, GoI on Friday released fresh guidelines for international travellers to control the spread of the virus. Health agencies across the globe are still figuring out how severe and lethal the virus can be. Several countries have been failing to control the spread, despite being aware of the origin and integrities of the monkeypox virus in humans since the 1970s. While the Covid pandemic is not over, only timely and strategised measures can prevent another major outbreak.

Read More
Advanced Biology Guest User Advanced Biology Guest User

Why India’s 75-Day Free Booster Drive is a Smart Move and How Can it be Made Smarter

By Harshit Kukreja and Mahek Nankani

To facilitate and enhance the ongoing mass vaccination campaign for Covid-19, the government has made booster doses free for citizens above 18 years of age for 75 days, starting July 15. This announcement has come amidst the rise of Covid-19 cases across India. The decision is not only bold, but also smart. This is because a staggering 92% Indians, who are currently eligible for a third dose, have not yet taken their shots and are now late receivers. The move is targeting many objectives together: increasing affordability, improving accessibility to more groups and strengthening the trust of the people in government authorities. However, poor awareness and implementation can hinder the ultimate objective of the decision.

Read More
Advanced Biology Guest User Advanced Biology Guest User

NFHS-5 Data Shows India Forgot Its Obesity Burden while Fighting Undernutrition

By Mahek Nankani and Harshit Kukreja

A few decades ago, obesity was not considered a public health issue. Even as late as the 1990s, obesity was only seen as a western concern, whereas undernutrition was more of a problem for developing nations like India. However, obesity is now afflicting more than 44 per cent of the world’s population. According to the data from the fifth round of the National Family Health Survey (NFHS), India is not far behind. Most government regimes have focused their efforts in recent years on combating malnutrition, with many schemes launched across the country. While the focus was important for that time, new data on obesity suggests that we may have forgotten the obesity burden.

Read More
Advanced Biology Guest User Advanced Biology Guest User

Health Star Rating for Packaged Food is a Welcome Move. But is It Enough?

By Mahek Nankani and Harshit Kukreja

In India, consumers have always had a difficult time separating unhealthy food items from their healthy counterparts. The country’s plan to implement a Health Star Rating (HSR) system for packaged food items is a long-pending move. The decision to approve HSR was made with an eye on rise in obesity, diabetes and hypertension in India. This rating will help in bringing about a behavioural change in the population. The Food Safety and Standards Authority of India (FSSAI) has been tasked with overseeing its implementation. The decision was made after a report was released by IIM Ahmedabad on ‘Consumer preferences for different nutrition front-of-pack labels in India’. The rating’s aim is to make customers aware and capable of making informed food choices.

Read More
Advanced Biology Guest User Advanced Biology Guest User

Ayurveda to Unani—traditional medicine systems can’t run on anecdotal evidence. Need research

By Mahek Nankani and Harshit Kukreja


In the last few years, there has been a push towards traditional medicine. And interest in indigenous medicinal systems has witnessed a boom in the ongoing Covid-19 pandemic. A big reason for this shift in public opinion can be credited to the massive promotion done by the Ministry of AYUSH. AYUSH was once a mere department under the Union health ministry and got promoted to a full ministry in 2014. Although there has been some anecdotal evidence that suggests that ancient forms of medicine such as Ayurveda, Unani, and Siddha are effective in treatment of a variety of diseases, there is dearth of reliable research to support such claims.

There have also been countless incidents that prove that harms caused by the traditional treatment are sometimes more than their supposed benefits. As we move towards achieving healthcare for all, it becomes extremely important that only evidence-based medicine is promoted and allowed.

Read More
Guest User Guest User

Current Booster Dose Policy is Not Enough. India Needs More Booster Shots To Beat The Fourth Wave

By Mahek Nankani and Harshit Kukreja

India has not begun booster doses for all adults. This is after fourteen months of initiation of the vaccination campaign. Apart from this, India has nine approved vaccines in its basket. The imprudent policy for administering booster doses is putting millions of lives at risk. According to the current policy, boosters are only open to the frontline workers and those above the age of 60. Understanding that the recent surge in cases due to the detection of new variants can be a cause of concern, India should start allocating third doses for all people.

Read More
Advanced Biology Guest User Advanced Biology Guest User

Omicron: Is India testing enough?

By Mahek Nankani and Harshit Kukreja

With the onslaught of the third wave, low testing rates have become a point of concern. With positivity rates touching 30 per cent in some cities as against the World Health Organisation (WHO)’s recommended five per cent, we do not see a proportional rise in the number of cases. This low number contributes to the narrative about the meekness of the Omicron variant hindering our implementation of the 3T strategy of testing, tracking and treatment.

Read More
Advanced Biology Mahek Nankani Advanced Biology Mahek Nankani

Omicron: Clinically milder but potentially deadlier

By Mahek Nankani and Harshit Kukreja

There has been a sudden surge in Covid cases across the country in the past few days. This increase can be attributed to the newest Covid-19 variant: Omicron. Ignorance, misconception, and a delay in response could result in India's even more fatal third wave. With India still reeling from the effects of earlier waves and the economic crisis, a new variant, while less fatal, could turn out to be deadlier.

Read More